Magdalena Plebanski Selected Research

Type II Tumor Necrosis Factor Receptors

12/2019	Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment.
1/2019	A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy.
1/2017	Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
1/2017	Synthetic Nanoparticles That Promote Tumor Necrosis Factor Receptor 2 Expressing Regulatory T Cells in the Lung and Resistance to Allergic Airways Inflammation.
1/2015	Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope.
2/2014	Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
10/2013	Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magdalena Plebanski Research Topics

Disease

33	Neoplasms (Cancer) 09/2021 - 05/2002
28	Malaria 11/2020 - 01/2002
20	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 06/2012
17	Inflammation (Inflammations) 01/2021 - 06/2010
16	Infections 07/2020 - 04/2003
5	Overweight 02/2020 - 11/2017
5	Diphtheria 01/2020 - 10/2004
5	Communicable Diseases (Infectious Diseases) 08/2009 - 10/2004
4	Human Influenza (Influenza) 10/2021 - 01/2013
4	Tetanus 01/2020 - 01/2015
4	Whooping Cough (Pertussis) 01/2020 - 01/2015
4	Asthma (Bronchial Asthma) 01/2013 - 01/2007
3	Ovarian Epithelial Carcinoma 06/2021 - 01/2017
3	Measles 01/2020 - 01/2015
3	Pneumonia (Pneumonitis) 11/2018 - 01/2017
3	Virus Diseases (Viral Diseases) 06/2010 - 04/2007
2	Ascites 12/2021 - 01/2017
2	Cytomegalovirus Infections (Inclusion Disease) 07/2020 - 01/2020
2	Obesity 02/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2006
2	Necrosis 01/2019 - 11/2017
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2006
2	Hypersensitivity (Allergy) 01/2018 - 01/2017
2	Wilms Tumor (Wilm's Tumor) 01/2018 - 03/2017
2	Poliomyelitis (Polio) 03/2016 - 10/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2014 - 02/2014
2	Vivax Malaria 02/2014 - 04/2011
2	Chronic Hepatitis C 12/2009 - 04/2007
1	Glaucoma 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2021
1	Autoimmune Diseases (Autoimmune Disease) 08/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2021
1	Disease Progression 01/2021

Drug/Important Bio-Agent (IBA)

36	VaccinesIBA 10/2021 - 01/2002
22	AntigensIBA 11/2020 - 05/2002
15	CytokinesIBA 01/2022 - 02/2003
15	Proteins (Proteins, Gene)FDA Link 08/2021 - 02/2003
12	Peptides (Polypeptides)IBA 08/2021 - 05/2002
10	EpitopesIBA 08/2021 - 03/2002
9	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2014
7	AntibodiesIBA 11/2020 - 02/2003
7	Polystyrenes (Polystyrene)IBA 07/2020 - 02/2012
7	Type II Tumor Necrosis Factor ReceptorsIBA 12/2019 - 10/2013
6	LigandsIBA 06/2021 - 05/2006
5	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022 - 04/2009
5	Interferon-gamma (Interferon, gamma)IBA 11/2020 - 04/2003
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2017
4	AutoantibodiesIBA 08/2021 - 12/2013
4	Interleukin-4 (Interleukin 4)IBA 11/2020 - 09/2004
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2020 - 05/2006
4	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 05/2013
4	AllergensIBA 01/2018 - 02/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 09/2021 - 01/2018
3	EnzymesIBA 06/2021 - 01/2018
3	AdipokinesIBA 02/2020 - 09/2018
3	Vitamin D FDA LinkGeneric 02/2020 - 11/2017
3	Immunologic Factors (Immunomodulators)IBA 01/2019 - 04/2009
3	Cancer VaccinesIBA 01/2018 - 09/2008
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2017 - 09/2011
3	Merozoite Surface Protein 1 (MSA1)IBA 02/2010 - 03/2002
2	CarnosineIBA 03/2021 - 09/2018
2	AntioxidantsIBA 01/2021 - 01/2020
2	Vaccine AdjuvantsIBA 07/2020 - 01/2018
2	AdiponectinIBA 02/2020 - 09/2018
2	Tranexamic Acid (AMCA)FDA Link 12/2019 - 01/2019
2	Cholecalciferol (Vitamin D3)FDA Link 01/2019 - 11/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2018
2	hydroxide ionIBA 01/2019 - 11/2017
2	NanovaccinesIBA 01/2018 - 09/2004
2	C-Reactive ProteinIBA 11/2017 - 06/2014
2	PolyethyleneimineIBA 02/2017 - 05/2013
2	Monoclonal AntibodiesIBA 01/2017 - 02/2003
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 08/2009
2	Measles VaccineIBA 01/2017 - 11/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2016 - 01/2016
2	PlatinumIBA 01/2016 - 01/2015
2	Azacitidine (5 Azacytidine)FDA Link 04/2015 - 02/2014
2	Lenalidomide (CC 5013)FDA Link 04/2015 - 08/2014
2	DNA VaccinesIBA 05/2013 - 03/2007
2	activin AIBA 01/2013 - 06/2010
2	Interleukin-13IBA 05/2011 - 06/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2010 - 08/2009
2	Interleukin-2 (IL2)IBA 08/2009 - 02/2003
1	Contrast MediaIBA 10/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2021
1	Hemagglutinins (Hemagglutinin)IBA 10/2021
1	PlasticsIBA 09/2021
1	AutoantigensIBA 08/2021
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 06/2021
1	ChemokinesIBA 06/2021
1	DipeptidesIBA 03/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	SugarsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021

Therapy/Procedure

17	Therapeutics 09/2021 - 02/2003
15	Immunotherapy 01/2020 - 02/2003
10	Drug Therapy (Chemotherapy) 09/2021 - 09/2008
1	Canes (Cane) 01/2021